COVID-19 And Your Clinical Trials
-
Adjusting To Clinical Trial Remote Monitoring During COVID-19: Working Smarter & Safer
4/10/2020
Industry colleagues recently convened to discuss issues and solutions specifically related to accelerating the uptake of remote monitoring (RM) — conducting monitoring activities that were previously conducted on-site (not to be confused with centralized monitoring) — in the wake of COVID-19.
-
COVID-19 And Its Impact On Clinical Trials
4/10/2020
Debora Araujo, founder and CEO of ClinBiz, recently hosted a live online discussion on the COVID-19 pandemic and the impact it will have on clinical trials. The purpose of the call was to share knowledge of how the pandemic might impact clinical trials and what sponsor companies can do to adapt.
-
Amid COVID-19, Clinical Trials Must Go On
4/8/2020
The COVID-19 pandemic continues to impact economies around the world, and many businesses and activities have been curtailed or shut down. Others, however, must continue to move forward. Clinical trials fall into the latter category.
-
Rethinking Recruitment Plans During The Pandemic
4/7/2020
Once the care and management of current clinical trial participants have stabilized, we can find some silver linings in the pause. Sponsors and CROs can use this opportunity to rethink their recruitment plans, support site sustainability, and intelligently prepare for the ultimate ramp up of trial enrollment.
-
Clinical Study Risk Management During The COVID-19 Pandemic
4/6/2020
While COVID-19 has proven to be an extremely trying obstacle for the life science community, it is crucial for organizations to not only focus on the short-term impacts of COVID-19 but on developing a long-term plan of action for how we return to business once the pandemic subsides.
-
Clinical Study Conduct During The COVID-19 Pandemic — Challenges & Solutions
4/6/2020
Life science companies across the world are scrambling to mitigate the impacts of COVID-19 on their clinical studies and business operations, and there are no clear-cut answers at this time, nor a one-size-fits-all solution. But what we do know is that we are all in this together and that this is another challenge that the biotech industry was built for.
-
Covid-19 Hastens Embrace Of Virtual Trials
3/30/2020
The COVID-19 pandemic is making clinical trials difficult for sponsors, sites, and patients. But will the changes needed to protect patients finally make virtual trials a reality?
-
How To Prepare For A GCP Inspection During COVID-19 (And Beyond)
3/27/2020
Facing an upcoming inspection, in many people’s opinion, is perhaps one of the most stressful experiences when working in clinical trials. But how much of this stress is self-inflicted, and what strategies could be deployed to dissipate and better channel the nervous energy released when the inspector comes a-knocking?
-
GlobalData: COVID-19 Will Cause Clinical Trials To Sputter
3/27/2020
The impact of the COVID-19 pandemic on clinical trials will be significant. A recent note from GlobalData shines a light on the impact COVID-19 will have on clinical trials. GlobalData interviewed 10 trial experts who noted the pandemic is already extensively impacting studies.
-
Clinical Trials And COVID-19: Don’t Attempt To Do It Alone
3/25/2020
As the COVID-19 virus continues to wreak havoc across the U.S. and the world, almost no segment of the economy has been spared its impact. That is certainly true of clinical trials conducted by the pharmaceutical industry.